According to the latest report by IMARC Group, titled “Atrial Fibrillation Treatment Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global atrial fibrillation treatment market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 13.7% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample:
Atrial fibrillation (AFib) refers to a type of cardiac condition in which irregular and rapid heart rate increase the risks of heart failure, stroke, and other heart-related complications. In this condition, the atrial chambers beat irregularly and out of coordination with the ventricle chambers of the heart, hence causing fatigue, shortness of breath, and heart palpitations. It may also lead to the formation of blood clots that can disrupt the blood flow to other organs. AFib can be treated with medications and other interventions to adjust the heart’s electrical impulses.
The rising prevalence of cardiovascular diseases (CVDs) is primarily propelling the market growth. Moreover, the escalating geriatric population who are more susceptible to such ailments is also providing a thrust to the market. Besides this, the increasing preferences for minimally invasive (MI) surgical procedures are further augmenting the demand for miniaturized surgical devices, remote nursing, and implant surgeries. Additionally, several technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and the introduction of innovative mapping and recording systems, are acting as another growth-inducing factor. Various other factors, including continuous improvements in the healthcare infrastructure and extensive R&D activities in the field of medical sciences, are projected to further drive the market in the coming years.
Atrial Fibrillation Treatment Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the atrial fibrillation treatment market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Abbott Laboratories ()
Boston Scientific Corporation
Hansen Medical Inc. (Auris Health)
Johnson & Johnson
Key Market Segmentation:
The report has segmented the atrial fibrillation treatment market on the basis of disorder type, treatment type, end-user and region.
Breakup by Disorder Type:
Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Permanent Atrial Fibrillation
Breakup by Treatment Type:
Breakup by End-User:
Ambulatory Surgical Centers
Breakup by Region:
Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/atrial-fibrillation-treatment-market
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Drivers and Success Factors
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800